IO Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IO Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • IO Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.81M, a 23.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.81M -$553K -23.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.94M -$598K -23.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.09M -$500K -19.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.26M -$234K -9.39% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.37M -$245K -9.38% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.53M +$386K +18% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $2.59M +$344K +15.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.49M +$193K +8.39% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $2.61M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.15M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.25M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $2.3M Jan 1, 2022 10-K 2024-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.